Free tool
FAERS Monitor: Cipro Hc
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020805 or its brand name (Cipro Hc, Ciprofloxacin Hydrochloride, Hydrocortisone). Reports on generic versions are filed under their own applications.
Reports
20,745
Serious
13,575
65% of reports
Hospitalization
6,047
Death reported
1,437
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug hypersensitivity2,484
- pain1,607
- neuropathy peripheral1,445
- nausea1,413
- diarrhoea1,408
- arthralgia1,388
- fatigue1,329
- urinary tract infection1,024
- dyspnoea991
- pain in extremity986
- headache985
- drug ineffective926
- anxiety906
- asthenia892
- dizziness860
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 331 |
| 2005 | 401 |
| 2006 | 457 |
| 2007 | 319 |
| 2008 | 792 |
| 2009 | 659 |
| 2010 | 710 |
| 2011 | 685 |
| 2012 | 622 |
| 2013 | 1,034 |
| 2014 | 1,211 |
| 2015 | 1,694 |
| 2016 | 2,846 |
| 2017 | 1,533 |
| 2018 | 1,484 |
| 2019 | 1,842 |
| 2020 | 1,248 |
| 2021 | 870 |
| 2022 | 532 |
| 2023 | 476 |
| 2024 | 380 |
| 2025 | 404 |
| 2026 | 215 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,414 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| neuropathy peripheralSignal | 1,445 | 15.6 | 14.9 | 19,552 |
| drug hypersensitivitySignal | 2,484 | 13.2 | 12.7 | 27,821 |
| urinary tract infectionSignal | 1,024 | 6.1 | 5.8 | 4,388 |
| pain in extremitySignal | 986 | 3.4 | 3.2 | 1,687 |
| arthralgiaSignal | 1,388 | 3.4 | 3.2 | 2,379 |
| anxietySignal | 906 | 3.2 | 3.0 | 1,411 |
| painSignal | 1,607 | 2.7 | 2.5 | 1,704 |
| astheniaSignal | 892 | 2.4 | 2.3 | 745 |
| diarrhoeaSignal | 1,408 | 2.2 | 2.1 | 964 |
| nausea | 1,413 | 1.8 | 1.7 | 532 |
| dyspnoea | 991 | 1.8 | 1.7 | 344 |
| dizziness | 860 | 1.7 | 1.6 | 282 |
| fatigue | 1,329 | 1.7 | 1.6 | 425 |
| headache | 985 | 1.6 | 1.5 | 224 |
| drug ineffective | 926 | 0.7 | 0.7 | 115 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.